Anti-cancer
Ruxolitinib
Also known as: Ruxolitinib Phosphate
CAS No.
941678-49-5
A JAK1/JAK2 inhibitor used in oral formulations for myelofibrosis, polycythemia vera, and graft-versus-host disease.
Ruxolitinib is a targeted JAK-inhibitor oncology/hematology API manufactured by NovaAcura Biotech under strict GMP quality systems. Full batch documentation and regulatory support are available for global formulation partners.
Applications & Uses
A JAK1/JAK2 inhibitor used in oral formulations for myelofibrosis, polycythemia vera, and graft-versus-host disease.
Full technical documentation, batch specifications and regulatory support (DMF/CEP) are available on request.
Need This Molecule at Scale?
Get in touch for pricing, lead times and full regulatory documentation.
Get In Touch